Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Fluorodeoxyglucose F18 × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Prostatic Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Oropharyngeal Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Anus Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thymus Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Neoplasms, Unknown Primary 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

X-Rays 3 Specimen Handling 3 Phantoms, Imaging 3 Nuclear Medicine Department, Hospital 3 Magnetic Resonance Spectroscopy 3 Biopsy 3 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 ulixertinib 1 tipifarnib 1 temsirolimus 1 tazemetostat 1 talazoparib 1 selpercatinib 1 palbociclib 1 olaparib 1 larotrectinib 1 irinotecan sucrosofate 1 Vincristine 1 Vemurafenib 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiation 1 Proton Therapy 1 Liquid Biopsy 1 LY3023414 1 Ifosfamide 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡